logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Experience of using totally implantable venous access devices in patients with hemoblastosis

[Original research]
Alexey V. Lyanguzov; Svetlana Leonidovna Kalinina; Olga Sergunina; Sergey Viktorovich Ignatiev; Maxim Razin;

Chemotherapy and adjuvant treatment in haemato-oncology is impossible without providing central venous access. Durable access to the central vein is necessary to reduce the number of complications of repeated catheterization with longterm programmed treatment. The use of fully implantable venous port systems for this purpose improves the quality of life of the patients. Data analysis was carried out in 149 patients with hematological malignancies, who received fully implantable venous port systems. Perioperative complications developed in 7 (4.7 %) patients. The period of use of port systems averaged 638 catheter-days. Infectious complications were detected in 0.12 cases per 1000 catheter-days and caused the removal of the device in 7 (4.7 %) patients. In 5 (3.3 %) patients, port systems were removed due to the development of thrombotic complications, and in 5 (3.3 %) persons complications of a mechanical nature were the reason for the removal. The study showed that the use of venous port systems in patients with hemoblastosis for a long period of time is an effective and safe means of providing central venous access.

Download

References:
1. Schiffer C. A., Mangu P. B., Wade J. C. [et al.]. Central venous catheter care for the patient with cancer: American society of clinical oncology clinical practice guideline. J. Clin. Oncol. 2013;1(10):1357-1370. https://doi.org/10.1200/JCO.2012.45.5733
2. Kornbau C., Lee K., Hughes G., Firstenberg M. S. Central line complications. Int. J. Crit. Illn. Inj. Sci. 2015;5(3):170-178. https://doi.org/10.4103/2229-5151.164940
3. Rykov M. Y., Polyakov V. G. Implantable venous ports in pediatric oncology: experience of single institution in Russia. J. Vasc. Access. 2016;12;17(4):345-347. https://doi.org/10.5301/jva.5000556
4. Heibl C., Trommet V., Burgstaller S. [et al.]. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur. J. Cancer Care. 2010;19:676-681. https://doi.org/10.1111/j.1365-2354.2009.01115
5. Samaras P., Dold S., Braun J. [et al.]. Infectious Port Complications Are More Frequent in Younger Patients with Hematologic Malignancies than in Solid Tumor Patients. Oncology. 2008;74:237-244. https://doi.org/10.1159/000151393
6. Shim J., Seo T., Song M. G. [et al.]. Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J. Radiol. 2014;15(4):494-500. https://doi.org/10.3348/kjr.2014.15.4.494
7. Lyanguzov A. V., Kolotilov L. V., Zagoskina T. P. Rhabdomyolysis in Patients with Hemoblastoses during Intensive Chemotherapy. Obshchaya reanimatologiya. – General Reanimatology. 2009;5(4):60-65. (In Russ.). https://doi.org/10.15360/1813-9779-2009-4-60
8. Napolitano M., Saccullo G., Marietta M. [et al.]. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfus. 2018;24:1-10. https://doi.org/10.2450/2018.0143-18
9. Wall C., Moore J., Thachil J. Catheter-related thrombosis: а practical approach. J. Int. Care Soc. 2016;17(2):160-167. https://doi.org/10.1177/1751143715618683
10. Baskin J., Pui C-H., Ulrike Reiss U. [et al.]. Management of occlusion and thrombosis associated with longterm indwelling central venous catheters. Lancet. 2009;374(9684):159. https://doi.org/10.1016/S0140-6736(09)60220-8
11. Wun T., Whitee R. H. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thromb. Res. 2010;125(2):96-102. https://doi.org/10.1016/S0049-3848(10)70024-4
12. Dhanger S., Vaidiyanathan B., Tripathy D. K. Internal jugular venous valve: well known, but mostly neglected. Indian J. Anaesth. 2016;60(8):602-603. https://doi.org/10.4103/0019-5049.187813
13. Jha C. K., Bichoo R. A., Mishra A. Ultrasound-guided placement of central venous port systems via the right internal jugular vein: are chest X-ray and/or fluoroscopy needed to confirm the correct placement of the device. World J. Surg. 2017;41(5):1396-1397. https://doi.org/10.1007/s00268-016-3811-8
14. Canfora A., Mauriello C., Ferronetti A. [et al.]. Efficacy and safety of ultrasound-guided placement of central venous port systems via the right internal jugular vein in elderly oncologic patients: our single-center experience and protocol. Aging Clin. Exp. Res. 2017;29(1):127-130. https://doi.org/10.1007/s40520-016-0680-9
15. Madabhavi I., Patel A., Sarkar M., Anand A., Panchal H., Parikh S. A Study of Use of «PORT» Catheter in Patients with Cancer: A Single-Center Experience. Clin. Med. Insights. Oncol. 2017;11:1179554917691031. https://doi.org/10.1177/1179554917691031
16. Vidal M., Genillon J. P., Forestier E. [et al.]. Outcome of totally implantable venous-access port-related infections. Med. Mal. Infect. 2016;46(1):32-38. https://doi.org/10.1016/j.medmal.2015.12.006
17. Tran H. A., Arellano M., Chamsuddin A. [et al.]. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk. Lymphoma. 2010;51(8):1473-1477. https://doi.org/10.3109/10428194.2010.481065
18. Ignatyev S. V., Zotina E. N., Fokina E. S., Lyanguzov A. V., Lagunova O. R., Ivashkina E. P. Procoagulantive state in patients with non-Hodgkin’s lymphomas. Tromboz, gemostaz i reologia. – Thrombosis, hemostasis and rheology. 2018;3(75):35-40. (In Russ.). https://doi.org/10.25555/THR.2018.3.0849
19. Lorch H., Zwaan M., Kagel C., Weiss H. D. Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc. Intervent. Radiol. 2001;24:180-184. 20. Cil B. E., Canyiğit M., Peynircioğlu B. [et al.]. Subcutaneous venous port implantation in adult patients: a single center experience. Diagn. Interv. Radiol. 2006;12:93-98.

Keywords: haemato-oncology, chemotherapy, central venous access, fully implantable device, catheter-related complications


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy